                Figure 5.  A combination of 225Ac-E4G10 with paclitaxel enhances the anti-tumor response.A, Tumor volume in the four treatment groups over time. Data are mean Â± S.E.M. B, Kaplan Meier survival curve of treated animals showing significant enhancement of animal survival when 225Ac-E4G10 therapy is followed by a course of paclitaxel. C, Absence of histopathologic damage in normal organs, assessed 10 days after cessation of 225Ac-E4G10 treatment.

